453 Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma

• Edward Gane,
• Niranjan Sardesai,
• Thomas Marron,
• Mark Yarchoan,
• Sarah Rochestie,
• Neil Cooch,
• Joann Peters,
• Ildiko Csiki,
• Alfredo Perales-Puchalt

Affiliations

Edward Gane

10 New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand

Niranjan Sardesai

Aff1 grid.421774.3Inovio Pharmaceuticals USA

Thomas Marron

3Icahn School of Medicine at Mount Sinai, New York, NY, USA

Mark Yarchoan

Aff1 0000 0000 8617 4175grid.469474.cThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 401 N Broadway, 1550 Orleans St., CRB2 5M44 21287 Baltimore MD USA

Sarah Rochestie

4GENEOS THERAPEUTICS, Philadelphia, PA, USA

Neil Cooch

4GENEOS THERAPEUTICS, Philadelphia, PA, USA

Joann Peters

4GENEOS THERAPEUTICS, Philadelphia, PA, USA

Ildiko Csiki

5City of Hope, Duarte, CA, USA

Alfredo Perales-Puchalt

4GENEOS THERAPEUTICS, Philadelphia, PA, USA